NASDAQ:OMPI - Obagi Medical Products Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous CloseN/AToday's RangeN/A52-Week RangeN/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Obagi Medical Products, Inc. (Obagi) is a specialty pharmaceutical company that develops, markets and sells, and is a provider of, topical aesthetic and therapeutic prescription-strength skin care systems and related products in the physician-dispensed market. Obagi systems and products are designed to prevent and improve the common and visible skin disorders in adult skin, including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, facial redness, and soft tissue deficits, such as fine lines and wrinkles. Obagi sells its products through a direct sales force in the United States and internationally through distribution partners in over 43 countries across North America, Central America, Europe, the Middle East and Asia. In April 2013, Valeant Pharmaceuticals International Inc acquired the entire share capital of Obagi Medical Products Inc. Receive OMPI News and Ratings via Email Sign-up to receive the latest news and ratings for OMPI and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:OMPI Previous Symbol CUSIPN/A CIK1375247 Webwww.obagi.com Phone+1-562-6281007Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Obagi Medical Products (NASDAQ:OMPI) Frequently Asked Questions What is Obagi Medical Products' stock symbol? Obagi Medical Products trades on the NASDAQ under the ticker symbol "OMPI." Has Obagi Medical Products been receiving favorable news coverage? News articles about OMPI stock have trended somewhat positive on Thursday, according to InfoTrie. The research firm scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Obagi Medical Products earned a daily sentiment score of 1.5 on InfoTrie's scale. They also gave news articles about the specialty pharmaceutical company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. How do I buy shares of Obagi Medical Products? Shares of OMPI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Obagi Medical Products' official website? The official website for Obagi Medical Products is http://www.obagi.com/. How can I contact Obagi Medical Products? Obagi Medical Products' mailing address is 50 Technology Drive, IRVINE, CA 92618, United States. The specialty pharmaceutical company can be reached via phone at +1-562-6281007. MarketBeat Community Rating for Obagi Medical Products (NASDAQ OMPI)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 86 (Vote Outperform)Underperform Votes: 82 (Vote Underperform)Total Votes: 168MarketBeat's community ratings are surveys of what our community members think about Obagi Medical Products and other stocks. Vote "Outperform" if you believe OMPI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OMPI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/25/2019 by MarketBeat.com StaffFeatured Article: What is systematic risk?